Citation Impact
Citing Papers
Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
2009
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
2006
Responsiveness and predictability of gait speed and other disability measures in acute stroke
2001
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group
2003
Vestibular Rehabilitation for Dizziness and Balance Disorders After Concussion
2010
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma
2003
Expression of bcl-2 Oncoprotein in Benign and Malignant Spindle Cell Tumors of Soft Tissue, Skin, Serosal Surfaces, and Gastrointestinal Tract
1998
Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma
2001
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
2009
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Gait Disorders in Older Adults
1996
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Serum Anticholinergic Activity and Motor Performance in Elderly Persons
2007
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Physical Performance Measures in the Clinical Setting
2003 Standout
Deficit and change in gait velocity during rehabilitation after stroke
1996
Function after through-knee compared with below-knee and above-knee amputation
1992
Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery
2012
Treatment of neuroendocrine tumors
1994
Neuroanatomical and Neurochemical Substrates of Timing
2010 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases
2004 Standout
Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis
2003
The role of executive function and attention in gait
2007 Standout
Rhythmic facilitation of gait training in hemiparetic stroke rehabilitation
1997
Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
2007
The time of our lives: Life span development of timing and event tracking.
2006 Standout
Bcl-2 expression in male breast carcinoma
1998
Walking speed of normal subjects and amputees
1993
Neuroendocrine gastrointestinal tumours
1996
Guideline for the Prevention of Falls in Older Persons
2001 Standout
Biomechanical gait alterations independent of speed in the healthy elderly: Evidence for specific limiting impairments
1998
The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death
1998
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study
2006
Carcinoid A Comprehensive Review
2003
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma
2009
Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas
2006
Right Portal Vein Ligation: A New Planned Two-Step All-Surgical Approach for Complete Resection of Primary Gastrointestinal Tumors with Multiple Bilateral Liver Metastases
2003
High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation
2014
Is automaticity of walking regained after stroke?
2006
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
2007
Comfortable and maximum walking speed of adults aged 20—79 years: reference values and determinants
1997 Standout
Population Representative Gait Speed and Its Determinants
2008
Update on the treatment of neuroendocrine tumors
2003
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors
2001
Metabolic cost, mechanical work, and efficiency during walking in young and older men
2006
Endometriosis
2004 Standout
The energy expenditure of normal and pathologic gait
1999 Standout
The Role of [18F]Fluorodeoxyglucose Positron Emission Tomography and [111In]-Diethylenetriaminepentaacetate-d -Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing’s Syndrome
2004
Cushing's syndrome
2006 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Relationship Between Test Methodology and Mean Velocity in Timed Walk Tests: A Review
2008
Lower Extremity Function and Subsequent Disability: Consistency Across Studies, Predictive Models, and Value of Gait Speed Alone Compared With the Short Physical Performance Battery
2000 Standout
Rhythmic auditory stimulation in gait training for Parkinson's disease patients
1996
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Motor recovery after stroke: a systematic review
2009 Standout
Walking Speed: Reference Values and Correlates for Older Adults
1996
Postural orientation and equilibrium: what do we need to know about neural control of balance to prevent falls?
2006 Standout
Carcinoid Tumors
1999
Gait Speed and Survival in Older Adults
2011 Standout
Reduced hip extension during walking: Healthy elderly and fallers versus young adults
2001
Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography
2005
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Isometric Strength and Endurance in Patients with Severe Rheumatoid Arthritis or Osteoarthrosis in the Knee Joints
1983
Gait Analysis Methods: An Overview of Wearable and Non-Wearable Systems, Highlighting Clinical Applications
2014 Standout
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
2008
Functional Performance in Community Living Older Adults
2003
Usefulness of the Berg Balance Scale in Stroke Rehabilitation: A Systematic Review
2008 Standout
Gait in the elderly
1997
Gait Analysis Using Wearable Sensors
2012 Standout
Vision assessment using the NIH Toolbox
2013 Standout
Enhanced Bone Regeneration Associated With Decreased Apoptosis in Mice With Partial HIF-1α Deficiency
2006 StandoutNobel
Rhythmic Auditor y Stimulation Improves Gait More Than NDT/Bobath Training in Near-Ambulatory Patients Early Poststroke: A Single-Blind, Randomized Trial
2007
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
2004
Fractal dynamics in physiology: Alterations with disease and aging
2002 Standout
Climate change associated effects on grape and wine quality and production
2010 Standout
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-X L and caspase-3-like proteases
1998
Effects of Footwear on Measurements of Balance and Gait in Women Between the Ages of 65 and 93 Years
2000
Gait Event Detection on Level Ground and Incline Walking Using a Rate Gyroscope
2010
A Brief Vestibular/Ocular Motor Screening (VOMS) Assessment to Evaluate Concussions
2014 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
The relationships between total acidity, titratable acidity and pH in grape tissue
2016
Dynamic markers of altered gait rhythm in amyotrophic lateral sclerosis
2000
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
2008 Standout
White Paper: “Walking Speed: the Sixth Vital Sign”
2009 Standout
Age- and Gender-Related Test Performance in Community-Dwelling Elderly People: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and Gait Speeds
2002 Standout
6-[F-18]Fluoro-l -Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess
2009
Breast Cancer in Men
2002 Standout
Instrumented shoes for pathological gait assessment
2003
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
2004
Works of K. Öberg being referenced
Neuroendocrine gastrointestinal tumors - A condensed overview of diagnosis and treatment
1999
Pancreatic neuroendocrine tumors: diagnosis with PET.
1995
Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo–tumor visualization using positron emission tomography with 11C-harmine
2003
Expression and prognostic significance of Bcl-2 in ovarian tumours
1995
The Role of Interferons in the Management of Carcinoid Tumors
1991
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
2004
Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography
2005
Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up
2009
Joint angle parameters in gait: reference data for normal subjects, 10-79 years of age.
1994
Basic gait parameters: reference data for normal subjects, 10-79 years of age.
1993
Gait Analysis with an Angle Diagram Technique:Application in Healthy Persons and in Studies of Marmor Knee Arthroplasties
1982
State of the art and future prospects in the management of neuroendocrine tumors.
2000
Prosthetic gait pattern in unilateral above-knee amputees.
1973
Knee mechanisms for through-knee prostheses
1983